COYA
Coya Therapeutics, Inc. Common Stock
NASDAQ: COYA · HEALTHCARE · BIOTECHNOLOGY
$4.07
-4.46% today
Updated 2026-04-29
Market cap
$95.47M
P/E ratio
—
P/S ratio
12.02x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$4 – $8
Volume
0.1M
Coya Therapeutics, Inc. Common Stock (COYA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-391266.00 | $-3.90M | $-7.24M | $-11.19M | $-10.29M | $-10.74M |
| Capital expenditures | $4.00 | $136804.00 | $4.00 | $1.00 | $0.00 | $0.00 |
| Depreciation | $16133.00 | $16133.00 | $27361.00 | $27361.00 | $27361.00 | — |
| Stock-based comp | — | $233222.00 | $207346.00 | $872248.00 | $2.66M | $4.29M |
| Free cash flow | $-391270.00 | $-4.04M | $-7.24M | $-11.19M | $-10.29M | $-10.74M |
| Investing cash flow | $-136804.00 | $-136804.00 | $-525000.00 | $-543186.00 | $-25000.00 | — |
| Financing cash flow | $9.11M | $-340584.00 | $9.36M | $38.43M | $16.03M | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |